Solid Biosciences Inc.
SLDB
$7.26
$0.212.98%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 38.88M | 36.74M | 35.40M | 34.45M | 33.30M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 179.21M | 169.70M | 156.82M | 142.92M | 129.73M |
| Operating Income | -179.21M | -169.70M | -156.82M | -142.92M | -129.73M |
| Income Before Tax | -174.33M | -167.14M | -154.08M | -139.68M | -124.70M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -174.33 | -167.14 | -154.08 | -139.68 | -124.70 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -174.33M | -167.14M | -154.08M | -139.68M | -124.70M |
| EBIT | -179.21M | -169.70M | -156.82M | -142.92M | -129.73M |
| EBITDA | -177.57M | -168.04M | -155.14M | -140.38M | -127.27M |
| EPS Basic | -2.02 | -2.49 | -2.80 | -2.99 | -3.04 |
| Normalized Basic EPS | -1.26 | -1.56 | -1.75 | -1.87 | -1.90 |
| EPS Diluted | -2.02 | -2.49 | -2.80 | -2.99 | -3.04 |
| Normalized Diluted EPS | -1.26 | -1.56 | -1.75 | -1.87 | -1.90 |
| Average Basic Shares Outstanding | 349.63M | 297.61M | 244.63M | 191.43M | 163.24M |
| Average Diluted Shares Outstanding | 349.63M | 297.61M | 244.63M | 191.43M | 163.24M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |